Browsing IQS by Subject "57"
Now showing items 1-6 of 6
-
A simplified implementation of the stationary liquid mass balance method for on‐line OUR monitoring in animal cell cultures
(Journal of Chemical Technology and Biotechnology. Vol.93, n.6 (2018), p.1757-1766, 2018-05)BACKGROUND Compared with other methods, the stationary liquid mass balance method for oxygen uptake rate (OUR) determination offers advantages in terms of estimation accuracy and reduction of stress. ... -
Assessment of the angiogenic potential of 2-deoxy-D-ribose using a novel in vitro 3D dynamic model in comparison with established in vitro assays
(Frontiers in Bioengineering and Biotechnology. Vol.7 (2020), 451, 2020-01)Angiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical ... -
Bioactivity evaluation of commercial calcium phosphate-based bioceramics for bone regeneration
(Afinidad. Vol.73, n.575 (2016), p.170-174, 2016-07)Calcium phosphate-based bioceramics constitute a great promise for bone tissue engineering as they chemically resemble to mammalian bone and teeth. Their use is a viable alternative for bone regeneration ... -
Dedifferentiated human articular chondrocytes redifferentiate to a cartilage-like tissue phenotype in a poly(ε-caprolactone)/self-assembling peptide composite scaffold
(Materials. Vol.9, n.6 (2016), 472, 2016-06)Adult articular cartilage has a limited capacity for growth and regeneration and, with injury, new cellular or biomaterial-based therapeutic platforms are required to promote repair. Tissue engineering ... -
Development of a three-dimensional bioengineered platform for articular cartilage regeneration
(Biomolecules. Vol.10, n.1 (2020), 52, 2019-12)Degenerative cartilage pathologies are nowadays a major problem for the world population. Factors such as age, genetics or obesity can predispose people to suffer from articular cartilage degeneration, ... -
In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models
(PLoS ONE. Vol.12, n.6 (2017), e0178931, 2017-06)Myotonic dystrophy type 1 (DM1) is a rare multisystemic disorder associated with an expansion of CUG repeats in mutant DMPK (dystrophia myotonica protein kinase) transcripts; the main effect of these ...